Megestrol Acetate-Induced Symptomatic Hypogonadism in a Male Patient
The hypothalamic-pituitary-adrenal (HPA) axis and the hypothalamic-pituitary-gonadal (HPG) axis are very sensitive and can be affected by external factors like stress, starvation, and medication. Medication-induced suppression of these axes can cause adrenal insufficiency (AI) and hypogonadism. Exog...
Main Authors: | Lubna Bashir Munshi, Yumiko Tsushima, Kwan Cheng, Maria Brito |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Case Reports in Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2018/7048610 |
Similar Items
-
Efficacy of megestrol acetate in treatment of 21 young patients with endometrial adenocarcinoma
by: Eftekhar Z, et al.
Published: (2007-05-01) -
Megestrol acetate for cachexia–anorexia syndrome. A systematic review
by: Vicente Ruiz‐García, et al.
Published: (2018-06-01) -
New Biopolymer Nanoparticles Improve the Solubility of Lipophilic Megestrol Acetate
by: Malwina Lachowicz, et al.
Published: (2016-02-01) -
A randomised, double blind, placebo-controlled trial of megestrol acetate or dexamethasone in treating symptomatic anorexia in people with advanced cancer
by: David C. Currow, et al.
Published: (2021-01-01) -
Hydrophilic and Functionalized Nanographene Oxide Incorporated Faster Dissolving Megestrol Acetate
by: Mohammad Saiful Islam, et al.
Published: (2021-03-01)